Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: A joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes - International Hypoglycaemia Study Group (Diabetologia, 2017)